Dual-dose Aprepitant to Reduce Postoperative Nausea and Vomiting After Laparoscopic Bariatric Surgery.
Condition(s):Postoperative Nausea and Vomiting; Bariatric SurgeryLast Updated:May 10, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Postoperative Nausea and Vomiting; Bariatric SurgeryLast Updated:May 10, 2023Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:January 23, 2024Not yet recruiting
Condition(s):HealthyLast Updated:January 26, 2024Not yet recruiting
Condition(s):Postoperative Nausea; VomitingLast Updated:November 30, 2022Not yet recruiting
Condition(s):NeoplasmsLast Updated:March 6, 2023Recruiting
Condition(s):Gynecological TumorLast Updated:December 28, 2023Not yet recruiting
Condition(s):Breast Cancer; Chemotherapy-induced Nausea and VomitingLast Updated:May 3, 2023Not yet recruiting
Condition(s):Heart FailureLast Updated:March 5, 2024Recruiting
Condition(s):Nausea With Vomiting Chemotherapy-InducedLast Updated:February 29, 2024Recruiting
Condition(s):Chemotherapy-induced Nausea and VomitingLast Updated:July 28, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.